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ABSTRACT 
Objective: The E. ulmoides and G. jasminoides (EG) tablets containing 67 mg E. ulmoides spray-dried extract (ESE) and 173 mg G. jasminoides spray-
dried extract (GSE) were prepared by employing the direct compression method. Due to the poor flowability and compressibility of the two spray-
dried extracts, various excipients were added at different ratios so that the blends can be compressed into tablets with the required standards. This 
study aimed at the cause-effect relations and optimization of the EG tablet formulation.  
Methods: Different diluents including dibasic calcium phosphate anhydrous (DCPA), silicified microcrystalline cellulose (SMCC), spray-dried lactose 
(SDL) and the active ingredients (blend of ESE and GSE at the ratio of 67:173, w/w) were separately investigated their own physical properties. The 
binary mixtures of the active ingredients with different ratios of DCPA, SMCC, and SDL were evaluated their flowability. D-optimal design based on 
three independent variables (% DCPA, % croscarmellose sodium (CCS) and % SMCC) was applied to evaluate the cause-effect relations and optimize 
the EG tablet formulation. The weight variation, disintegration time, hardness and friability were investigated as four dependent variables.  
Results: The flowability of the powders was found to be affected by the particle size distribution, particle shape and density. The three diluents 
could significantly improve the flowability of the active ingredients. All independent variables had significant effects on the dependent variables. An 
increase in % SMCC reduced the weight variation, hardness and increased the friability of tablets. Disintegration time was found to be in the 
negative relations with % CCS. The tablet hardness was in positive relations with % DCPA. The optimized EG tablet formulation composed of 9 % 
DCPA (w/w), 35 % SMCC (w/w), and 14 % CCS (w/w) of the excipient blend. The weight variation, disintegration time, hardness and friability of the 
optimized EG tablets were found to be 1.8 %, 11.7 min, 61.4 N, and 0.5 %, respectively.  
Conclusion: The ESE and GSE could be formulated into tablet by using direct compression method. The cause-effect relations and optimization of 
EG tablet formulation were studied and reported for the first time.  
Keywords: Spray-dried extract, Direct compression, Optimization, Cause-effect relations, BCPharSoft OPT software, Eucommia ulmoides, Gardenia 
jasminoides 




Tablets are solid dosage forms for drug delivery, representing two-
thirds of the global market due to the convienience of dosing, ease of 
manufacture, stability in comparison with liquid and semi-solid 
formulations [1]. Wet granulation, dry granulation and direct 
compression have been the three major methods for tablet 
preparation [2]. Of the three methods, direct compression is the 
more advantageous one due to its low cost, fewer unit operations, 
less time consumption, and low microbial level. 
Eucommia ulmoides and Gardenia jasminoides extracts have been 
reported to possess anti-hypertensive activities associated with several 
mechanisms. In order to prepare the EG tablet containing 67 mg E. 
ulmoides spray-dried extract (ESE) and 173 mg G. jasminoides spray-
dried extract (GSE), the direct compression method was employed. In 
general, the spray-dried extracts are amorphous and tend to have poor 
physical-chemical properties [3]. Appropriate flowability is essential to 
ensure the homogenous and rapid flow of the tableting blend and thus, 
weight and content uniformity of tablets. The poor flowability and 
compactability of ESE and GSE could be the major challenges that need 
to be overcome to obtain the tablets of outstanding quality. Different 
direct compression excipients with different ratios were employed to 
improve the quality of EG tablets. This study, for the first time, reported 
the cause-effect relations and formulation optimization of the tablets 
containing ESE and GSE.  
MATERIALS AND METHODS 
Materials 
ESE and GSE were obtained from BV Pharma JSC (Vietnam). SMCC 
(Prosolv® SMCC 90) and CCS (Vivasol®) were received from JRS 
Pharma (Rosenberg, Germany) via Sapharchem Co., Ltd (Vietnam). 
Magnesium stearate (MS) was a gift from Brenntag (Denmark). 
DCPA (A-Tab®) was received from Innophos (Cranbury, NJ) via Asia 
Shine Co. Ltd. (Vietnam). Spray-dried lactose (SDL, Flowlac® 100) 
was kindly provided by Meggle Excipients and Technology 
(Wasserburg, Germany). 
Scanning electron microscopy 
The surface features and morphology of ESE, GSE and tablet blend 
were analyzed by using scanning electron microscopy (SEM) (JSM-
IT100, JEOL, Tokyo, Japan). A thin layer of each sample was placed 
on carbon double-sided adhesive tab, mounted onto a brass sample 
holder and sputter-coated with gold particles and observed under 
the microscope [4, 5]. The SEM-images were taken with 1000x 
magnification. Images of tablet blend were also taken in order to 
investigate the arrangement of different particles in the blend before 
tableting. 
Particle size distribution 
The particle size and size distribution of ESE and GSE were 
separately evaluated by laser diffraction using a Master sizer 3000 
(Malvern Instruments, Malvern, UK). The particle size was 
expressed as geometric median diameter based on a volume 
distribution (d50), and the polydispersity of the samples was 
expressed by the span. 
Effects of dilluents on the flowability of active ingredients 
12 powder blends (A1–A12) containing different dilluents (SMCC, 
DCPA, SDL) at different ratios (40%, 50%, 60% and 70%, w/w) and 
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active ingredients were prepared. Each powder mixture was then 
characterized its bulk density, tapped density, compressibility index 
and Hausner’s ratio for evaluating the effects of diluents on the 
flowability of active ingredients. 
Characterization of powder  
30 g powder was gently poured into a 100 ml measuring cylinder 
and the volume (Vo) occupied by the powder without tapping was 
recorded. After 200 taps on the table, the occupied volume (V) was 
read. Each experiment was carried out in triplicate. The bulk density 
(do), tapped density (d), the compressibility index (CI) and 





Where m is the total weight of the powder blend. 
Tablet preparation  
The EG tablets were prepared by using direct compression method. 
Ingredients (ESE, GSE, SMCC, DCPA, SDL and CCS) with different 
ratios were passed through 40 mesh sieve, weighed and mix well 
before adding magnesium stearate. Powder blend of each 
formulation was mixed by tumbling action and then compressed 
using a single-punch tableting machine (Riva Minipress MII, Riva, 
Germany) with an 11 mm diameter concave punch.  
Uniformity of tablet weight 
Twenty tablets from each batch were randomly chosen and 
individually weighed using a digital analytical balance (XB 220A; 
Precisa, Dietikon, Switzerland). The average weight of the tablets 
and percentage deviation of each individual tablet from the average 
weight were calculated. 
Hardness test 
The hardness of the EG tablet was determined by using a hardness 
tester (TBH 210, Erweka, Germany). Ten tablets from each batch 
were selected at random. Each tablet was placed radically between 
the jaws of the hardness tester and the diametral compression force 
was applied until the tablet broken. The average hardness and 
standard deviation were calculated. 
Friability test  
Friability was measured using a friability tester (Model: TA3B, 
Erweka, Germany). Ten tablets of each formulation were placed in a 
drum operated at 25 rpm for 4 min, following the standard USP 38 
method [6]. The tablets were dedusted and weighed before and after 
using the tester to determine the loss in weight. Tablet friability was 
calculated using the following equation:  
 
Where Wi and Wf are the initial and final weights of all tablets, 
respectively. Less than or equal to 1% weight loss was considered 
acceptable. 
Disintegration time 
Tablet disintegration tests were carried out according to USP 38 [6]. 
Six tablets were separately placed into the basket-rack assembly of a 
disintegration apparatus (ZT 501, Erweka, Germany). The tablets 
were immersed into 900 ml distilled water thermostatically 
maintained at 37±0.5 °C. The time for complete disintegration of 
each tablet with no solid residue remained or only a trace amount of 
soft residue remained on the wire mesh was recorded. The 
disintegration time of each formulation was measured three times 
and the results were recorded as the mean±standard deviation. 
Experimental design and data analysis 
14 different formulations F1–F14 according to the D-optimal design 
were generated by Design Expert software (version 6.0.6, Stat–Ease 
Inc., Minneapolis, USA) to study the effects of independent variables 
on dependent variables. The constituents of the EG tablet 
formulations included ESE and GSE as active ingredients, mixtures of 
DCPA, SDL and SMCC as fillers whereas CCS and MS acted as 
superdisintegrant and lubricant, respectively.  
Percentages of DCPA (X1), % SMCC (X2) and % CCS (X3) were 
selected as three independent variables whereas weight variation 
(Y1), disintegration time (Y2), hardness (Y3) and friability (Y4) were 
chosen as four dependent variables. Percentage of DCPA (X1) and % 
CCS (X3) were studied at three levels and % SMCC (X2) was studied 
at two levels. The selection ranges of independent variables were 
based on the results of initial trials.  
All experiments were carried out in triplicate and the results were 
exhibited as mean±standard deviation. The data were then analyzed 
by BCPharSoft OPT software (Vietnam) and the best model was 
selected. The optimized formulation was obtained and repeated in 
triplicate for further validation. The predicted data created by 
BCPharSoft OPT software were compared with the observed 
response data of the optimized formulation using SPSS version 20.0 
(SPSS, Inc., Chicago, IL, USA).  
RESULTS AND DISCUSSION 
Morphology and particle size distribution of ESE and GSE 
Fig. 1 and fig. 2 show the morphology and particle size distribution 
of ESE and GSE, respectively. The SEM results revealed that the 
particles of ESE and GSE were in spherical or almost spherical 
shapes with smooth surfaces. The average diameters of ESE and GSE 






Fig. 1: SEM images of (a) ESE and (b) GSE 
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As the general guide, the maximum angles of repose of powder 
close to 25 ° correspond to excellent flow properties. The size and 
shape of the powders have been reported to influence their 
flowability. The larger, the more spherical the particles are, the 
better they flow [7]. ESE and GSE powders with angles of repose 
greater than 45 ° were found to possess a very poor flowability in 
spite of their spherical shapes. This phenomenon could be 
explained by the cohesiveness of the small particles of ESE and 
GSE which caused by the electrostatic charge interactions. As a 
result, the ESE and GSE powder particles have tendancy to 
aggregate and obstruct the free-flowing of the two spray-dried 
extracts. 
 
(a)  (b)  
Fig. 2: Particle size distributions of (a) ESE and (b) GSE 
 
Effects of dilluents on the flowability of active ingredients 
The bulk density, tapped density, Hausner’s ratio and the 
compressibility index of the investigated powder mixtures including 
active ingredients (blend of ESE and GSE at the ratio of 67:173, 
w/w) and different diluents are shown in table 1. 
The Hausner’s ratio and the compressibility index of the investigated 
mixtures (A1–A12) decreased when the percentages of the diluents 
increased. Therefore, the flowability of investigated mixtures was 
improved once the diluents were added. The bulk density and tapped 
density of the investigated mixtures increased due to the presence of the 
diluents which possess the higher densities and the rearrangement of 
particles in the powder mixtures. Due to the small particle size (<35 μm), 
the large surface area of active ingredients allowed the increase in the 
surface area/volume ratio thus increasing the interparticulate 
attractive forces among themselves, causing the large friction forces 
and hence the poor flowability of the active ingredient powder. When 
being mixed with diluents identified with larger particle size (the 
aveage particle sizes of SMCC, DCPA and SDL were 121 μm, 178 μm 
and 135 μm, respectively), the active ingredient particles filled in the 
gaps between the contact surfaces of the large particles. When the 
diluents rolled or slided, the gravity forces could overcome interparticle 
forces such as the electrostatic or van der Waals interactions and hence 
led to the movement of active ingredient particles.  
Therefore, the flowability of the investigated powder mixtures was 
improved.
  
Table 1: Properties of powder mixtures containing active ingredients and different diluents 

















H CI  
(%) 
A1 59 40 - - 1 0.42±0.003 0.63±0.013 1.49±0.021 33.02±0.97 
A2 49 50 - - 1 0.49±0.005 0.69±0.009 1.42±0.005 29.35±0.28 
A3 39 60 - - 1 0.56±0.003 0.76±0.006 1.37±0.535 27.16±0.60 
A4 29 70 - - 1 0.65±0.003 0.83±0.003 1.28±0.012 21.74±0.90 
A5 59 - 40 - 1 0.34±0.003 0.51±0.009 1.47±0.014 32.18±0.32 
A6 49 - 50 - 1 0.37±0.008 0.52±0.003 1.41±0.007 29.07±0.35 
A7 39 - 60 - 1 0.38±0.003 0.52±0.003 1.39±0.361 27.92±0.73 
A8 29 - 70 - 1 0.40±0.006 0.52±0.006 1.30±0.023 23.33±0.92 
A9 59 - - 40 1 0.38±0.003 0.58±0.004 1.53±0.011 34.45±0.48 
A10 49 - - 50 1 0.43±0.002 0.61±0.002 1.43±0.004 30.12±0.21 
A11 39 - - 60 1 0.48±0.002 0.67±0.003 1.38±0.012 27.42±0.97 
A12 29 - - 70 1 0.55±0.004 0.70±0.004 1.28±0.005 21.82±0.90 
Values are expressed as mean±SD (n=3). 
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The investigated mixture contained 40% SMCC as diluent showed 
the better flowability (lower Hausner’s ratio) when compared with 
the investigated mixtures contained SDL or DCPA at the same ratio 
(fig. 3). The rough surfaces and irregular shapes of SMCC (fig. 4b) 
may leave more spaces for small particles of active ingredients to be 
adhered and hence improved the flowability of the investigated 
mixture better than DCPA and SDL with the almost spherical shapes 
(fig. 4a and fig. 4c). 
However, at the diluent ratios of 60% and 70%, the investigated 
mixtures contained SDL or DCPA gave the lower Hausner’s ratios and 
thus better flowability compared with the investigated mixture 
contained SMCC. It could be explained by the almost spherical shapes 
and the higher densities of SDL (d=0.71 g/ml) and DCPA (d = 0.82 
g/ml). As a result, different mechanisms of flowability enhancement 
such as the optimized shape, density and size of particles should be 
employed for improving the flowability of the active ingredients. 
Optimization data analysis and validation of optimization model 
The levels of three independent variables and the constraints of the 










Fig. 4: SEM images of (a) DCPA; (b) SMCC; (c) SDL and (d) CCS 
 
Table 2: Variables in experimental design 
 Level 
Independent variables Low Medium High 
X1: % DCPA (w/w) 0 15 30 
X2: % SMCC (w/w) 35 55 - 
X3: % CCS (w/w) 0 7 14 
Dependent variables Constraints 
Y1: Weight variation (%, w/w) Minimum 
Y2: Disintegration time (min) Minimum 
Y3: Hardness (N) Maximum 
Y4: Friability (%, w/w) Minimum 
Table 3 shows 14 formulations generated by Design Expert software. The ranges of weight variation (Y1), disintegration time (Y2), hardness (Y3) and 
friability (Y4) were found to be 1.15–2.34 %, 11.7–21.42 min, 53.5–134.7 N and 0.155–0.683%, respectively. 
 
Table 3: The independent variables of 14 formulations (F1-F14) and their responses 
Formulation Independent variables Dependent variables 
X1 X2 X3 Y1 (%) Y2 (min) Y3 (N) Y4 (%) 
F1 0 35 7 2.12±0.20 11.70±0.83 95.5±10.1 0.408±0.134 
F2 15 35 14 1.82±0.47 12.71±1.14 67.8±5.3 0.432±0.026 
F3 15 55 14 1.50±0.24 11.34±0.79 58.1±6.1 0.527±0.055 
F4 30 35 14 2.34±0.99 13.88±0.45 61.6±4.1 0.414±0.060 
F5 30 55 14 1.45±0.13 11.28±0.61 53.5±2.0 0.683±0.082 
F6 15 55 0 1.41±0.41 21.42±0.45 108.5±3.7 0.216±0.039 
F7 0 35 14 1.83±0.41 10.53±0.46 61.8±5.6 0.503±0.042 
F8 0 35 0 1.39±0.37 16.60±1.79 127.8±13.7 0.194±0.092 
F9 15 35 7 1.67±0.13 14.32±1.37 96.7±1.2 0.155±0.179 
F10 0 55 0 1.67±0.71 19.40±1.58 102.9±0.9 0.197±0.103 
F11 15 35 0 1.49±0.19 19.15±2.18 134.7±16.6 0.242±0.062 
F12 0 55 7 1.49±0.27 12.88±1.17 73.1±1.5 0.259±0.184 
F13 30 55 7 1.56±0.17 14.65±1.85 75.7±5.7 0.432±0.062 
F14 30 55 0 1.15±0.23 11.70±0.83 102.2±8.5 0.222±0.073 
X1 (% DCPA); X2 (% SMCC); X3 (% CCS); Y1 (weight variation); Y2 (disintegration time); Y3 (hardness); Y4 (friability). Values are expressed as 
mean±SD (n=3). 
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Table 4: Composition of 14 formulations 
Ingredients F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 F11 F12 F13 F14 
ESE (mg) 67 67 67 67 67 67 67 67 67 67 67 67 67 67 
GSE (mg) 173 173 173 173 173 173 173 173 173 173 173 173 173 173 
DCPA (X1) (mg) 0 53 53 106 106 53 0 0 53 0 53 0 106 106 
SMCC (X2) (mg) 124 124 195 124 195 195 124 124 124 195 124 195 195 195 
CCS (X3) (mg) 25 50 50 50 50 0 50 0 25 0 0 25 25 0 
SDL (mg) 205 127 57 74 4 106 181 230 152 159 177 135 28 53 
MS (mg) 6 6 6 6 6 6 6 6 6 6 6 6 6 6 
Total (mg) 600 600 600 600 600 600 600 600 600 600 600 600 600 600 
The compositions of 14 formulations are shown in table 4. The data in table 4 were used as inputs for BCPharSoft OPT to study on the cause-effect 
relations and optimize the EG tablet formulation. 
Training parameters were set at:  
-Test groups: Y1(1,6), Y2(5,6), Y3(3,8) and Y4(1,8) 
-Transfer function: Back Propagation Learning 
 
Table 5: Model statistics from BCPharSoft OPT outputs 
Dependent variables  R2training R2test 
Y1 0.99 1.00 
Y2 0.99 1.00 
Y3 0.99 1.00 
Y4 0.99 1.00 
Table 5 shows that all R2 training and R2 test values were more than 0.9 indicated the very good reliability of the models and these models could be 
used for multivariate optimization.  
 
The three-dimensional (3D) response surface plots of the fit models 
were depicted for better understanding of the cause-effect 
relationships between the independent and dependent variables. 
Each 3D diagram illustrated the effects of two independent variables 
on the dependent variables at one time while the third variable was 
kept constant. 
Effects of variables on weight variation 
When X2 (% SMCC) was more than 45 %, the weight variation of 
EG tablets (Y1) was low (fig. 5a). An increase in X2 (% SMCC) 
caused the decrease in weight variation (Y1) while % DCPA (X1) 
did not have significant influences on weight variation (Y1). This 
could be explained by the rough surfaces of SMCC which led to 
more active ingredient particles to be adhered, caused the 
flowability enhancement of the powder mixtures and improved 
the EG tablet uniformity and hence reduced the weight variation 
(Y1). 
Fig. 5a shows that when % SMCC (X2) was lower than 45%, an 
increase in % DCPA (X1) resulted in higher weight variation (Y1). The 
same result was also reported in the study of Zhang Y [8]. Among the 
three employed diluents, DCPA has the highest density which could 
cause the signification difference in density between DCPA and the 
other ingredients in the powder mixtures and led to the poor 
powder flowability and thus the higher weight variation (Y1).  
When % SMCC (X2) was less than 45 %, an increase in % CCS (X3) led 
to an increase in weight variation (Y1) (fig. 5b). CCS has the small 
particle size, the low density and the long shape (fig. 4d) which could 
cause the poor flowability of the tableting powder mixtures and an 
increase in weight variation (Y1) [9, 10]. 
 
(a)  (b)  
Fig. 5: Response surface plots showing the effects of (a) % DCPA (X1) and % SMCC (X2) on weight variation (Y1); (b) % SMCC (X2) and % CCS 
(X3) on weight variation (Y1) 
 
Effects of variables on disintegration time 
When % SMCC (X2) increased, the disintegration time (Y2) decreased 
(fig. 6a). SMCC is the silicified microcrystalline cellulose, therefore, it 
has the nature of cellulose making itself could uptake water, 
increase the tablet volume and made the tablet disintegrated faster 
and thus also acted as a disintegrant [11]. The same result was also 
reported in the study of Kachrimanis K [12]. 
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Fig. 6b depicts that an increase in % CCS (X3) caused a decrease in 
disintegration time (Y2). CCS is a superdisintegrant which draws 
water into tablets. When contacting with water, CCS swelled, 
significantly increased in the volume and caused the tablets to break 
apart [13]. The same results were also found in the study of Ferrero 
C [14] and Shakar AAM [11]. 
 
(a)  (b)  
Fig. 6: Response surface plots showing the effects of (a) % DCPA (X1) and % SMCC (X2) on disintegration time (Y2); (b) % DCPA (X1) and % 
CCS (X3) on disintegration time (Y2) 
 
Effects of variables on hardness 
Fig. 7a shows that the hardness (Y3) decreased as % SMCC (X2) 
increased. The same result was also reported in the study of Van Veen B 
[15]. The rule could be explained by the elastic deformation of SMCC 
which may not create the new surfaces during the compression process. 
Moreover, due to the silicified layer covered the SMCC particles, the 
interactions between SMCC and the other particles in the tableting blend 
could be reduced and led to the reduction of hardness (Y3). 
It could be observed from fig. 7a that hardness (Y3) increased 
with % DCPA (X1). The increase in hardness (Y3) could be 
explained by the brittle deformation of DCPA which created new 
surfaces, reduced the particle size and rearranged the tableting 
blend. 
Hardness data (table 3) show that the formulations containing 14 % CCS 
(F2, F3, F4, F5, F7) had the low hardness. Ferrero C [14] and Solaiman A 
[16] reported that CCS had the negative effect on tablet hardness. This 
could be explained by the nature of CCS which has the elastic 
deformation causing the weak binding between themselves and others 
particles. As a result, an increase in CCS (X3) could cause the decrease in 
hardness (Y3) (fig. 7b). 
 
(a)  (b)  
Fig. 7: Response surface plots showing the effects of (a) % DCPA (X1) and % SMCC (X2) on hardness (Y3); (b) % SMCC (X2) and % CCS (X3) 
on hardness (Y3) 
 
Effect of variables on friability 
It is evident from fig. 8 that when % DCPA (X1) was higher than 15%, 
the tablet friability (Y4) increased propotionally with % SMCC (X2). 
The rough surface and irregular shapes of SMCC particles caused 
more porosities and cavities which reduced the compression 
efficiency. Moreover, SMCC also had the elastic deformation caused 
the decrease in tablet hardness and the increase in tablet friability. 
Therefore, the rough surface, the irregular shapes and the elastic 
deformation could be the main reasons causing the high friability 
(Y4) of the tablet. 
When % DCPA (X1) was lower than 15%, friability (Y4) decreased when 
% DCPA (X1) increased. The deformation mechanism of excipients could 
affect the tablet hardness and thus the tablet friability. DCPA with the 
brittle deformation could be broken into the smaller pieces with new 
surfaces. The smaller pieces may fill the gaps between the particles and 
the new surfaces may create the tablet with lower friability.  
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Fig. 8: Response surface plot showing the effects of % DPCA (X1) 
and % SMCC (X2) on the friability (Y4) of EG tablet (n=3) 
Optimization of EG tablet formulation 
The optimized EG tablet formulation was achieved by BCPharSoft 
OPT software with 40% active ingredients (blend of ESE and GSE 
at the ratio of 67:173, w/w) and 60 % excipients including DCPA, 
SMCC and CCS at the percentages of 9 %, 35 % and 14 %, 
respectively. In order to confirm the validity of the optimization 
procedure, three replicated batches of the optimized EG tablet 
formulation were prepared and statistically compared with the 
predicted data using one sample T-test (table 6). Weight variation 
(Y1), disintegration time (Y2), hardness (Y3) and friability (Y4) of 
the optimized EG tablet were found to be at 1.66±0.08 %, 
12.44±1.18 min, 61.9±3.7 N and 0.43±0.05 %, respectively. It was 
demonstrated that all predicted values were in good agreement 
with the observed values (p>0.05). 
  
Table 6: Comparison of the predicted and observed responses of the optimized EG tablet formulation 
Responses Y1 (%) Y2 (min) Y3 (N) Y4 (%) 
Predicted 1.8 11.7 61.4 0.5 
Observed 1.66±0.08 12.44±1.18 61.9±3.7 0.43±0.05 
P-values 0.100 0.389 0.819 0.137 
Values are expressed as mean±SD (n=3). 
 
Particle interactions in the tableting blend of the optimized EG 
tablet formulation 
SEM images from fig. 9 revealed the mechanical entanglements due to 
the shape, size and roughness of the particles in the tableting blend of 
the optimized EG tablet formulation. The small spherical particles of 
the active ingredients tended to dispose on the surfaces of the bigger 
particles (excipients) and rough surface particles more than smooth 
one. As a result, the friction of rough particles was decreased. The 
particles of excipients (bigger sizes) were dispersed, indicating a lack 
of cohesive interactions between them. This could be the major 
mechanism for improving the flowability of the active ingredients. 
 
  
Fig. 9: SEM images of the optimized EG tablet blend (x500) 
 
CONCLUSION 
The ESE and GSE could be formulated into tablet by using direct 
compression method with a total percentage of active ingredients up 
to 40% (w/w). The effects of three independent variables (% DCPA, 
% SMCC and % CCS) on four dependent variables (weight variation, 
disintegration time, hardness and friability of EG tablet) were 
investigated. All investigated independent variables were 
demonstrated the significant effects on all dependent variables and 
the cause-effects relationships were raised up. The optimized EG 
tablet formulation contained 40% active ingredients (blend of ESE 
and GSE at the ratio of 67:173, w/w) and 60 % excipients including 
DCPA, SMCC and CCS at the percentages of 9 %, 35 % and 14 %, 
respectively.  
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